Tag: CX 2026
“Incredible results”: C-GUARDIANS II data point to safety and efficacy of...
New findings from the C-GUARDIANS II study indicate that the CGuard Prime carotid stent system (InspireMD) achieves high procedural success, durable early luminal restoration,...
CX 2026: Carotid trial debate highlights “key question” of cost-effectiveness
An audience poll asking, ‘What do we believe: ECST-2 or CREST-2?’ following a debate at the 2026 Charing Cross (CX) Symposium (21–23 April, London,...
